236 related articles for article (PubMed ID: 28668085)
1. Utility of somatosensory evoked potentials in the assessment of response to IVIG in a long-lasting case of chronic immune sensory polyradiculopathy.
Clerici AM; Nobile-Orazio E; Mauri M; Squellati FS; Bono GG
BMC Neurol; 2017 Jul; 17(1):127. PubMed ID: 28668085
[TBL] [Abstract][Full Text] [Related]
2. Utility of somatosensory evoked potentials in chronic acquired demyelinating neuropathy.
Yiannikas C; Vucic S
Muscle Nerve; 2008 Nov; 38(5):1447-1454. PubMed ID: 18932207
[TBL] [Abstract][Full Text] [Related]
3. Non-anti-MAG DADS neuropathy as a variant of CIDP: clinical, electrophysiological, laboratory features and response to treatment in 10 cases.
Larue S; Bombelli F; Viala K; Neil J; Maisonobe T; Bouche P; Musset L; Fournier E; Léger JM
Eur J Neurol; 2011 Jun; 18(6):899-905. PubMed ID: 21199182
[TBL] [Abstract][Full Text] [Related]
4. Treatment of immune-mediated, dysimmune neuropathies.
Finsterer J
Acta Neurol Scand; 2005 Aug; 112(2):115-25. PubMed ID: 16008538
[TBL] [Abstract][Full Text] [Related]
5. Chronic immune sensory polyradiculopathy: a possibly treatable sensory ataxia.
Sinnreich M; Klein CJ; Daube JR; Engelstad J; Spinner RJ; Dyck PJ
Neurology; 2004 Nov; 63(9):1662-9. PubMed ID: 15534252
[TBL] [Abstract][Full Text] [Related]
6. Long-term effects of intravenous immunoglobulin in CIDP.
Vucic S; Black K; Baldassari LE; Tick Chong PS; Dawson KT; Cros D
Clin Neurophysiol; 2007 Sep; 118(9):1980-4. PubMed ID: 17604689
[TBL] [Abstract][Full Text] [Related]
7. Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy.
Eftimov F; Winer JB; Vermeulen M; de Haan R; van Schaik IN
Cochrane Database Syst Rev; 2009 Jan; (1):CD001797. PubMed ID: 19160200
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment of chronic inflammatory demyelinating polyneuropathy (CIDP) in systemic lupus erythematosus (SLE) with oral cyclophosphamide.
Jasmin R; Sockalingam S; Shahrizaila N; Cheah TE; Zain AA; Goh KJ
Lupus; 2012 Sep; 21(10):1119-23. PubMed ID: 22433918
[TBL] [Abstract][Full Text] [Related]
9. Treatment of chronic immune-mediated neuropathies: chronic inflammatory demyelinating polyradiculoneuropathy, multifocal motor neuropathy, and the Lewis-Sumner syndrome.
Sederholm BH
Semin Neurol; 2010 Sep; 30(4):443-56. PubMed ID: 20941678
[TBL] [Abstract][Full Text] [Related]
10. Sensory chronic inflammatory demyelinating polyneuropathy: an under-recognized entity?
Ayrignac X; Viala K; Koutlidis RM; Taïeb G; Stojkovic T; Musset L; Léger JM; Fournier E; Maisonobe T; Bouche P
Muscle Nerve; 2013 Nov; 48(5):727-32. PubMed ID: 23424105
[TBL] [Abstract][Full Text] [Related]
11. [Treatment options for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)].
Kuntzer T
Rev Neurol (Paris); 2006 Apr; 162(4):539-43. PubMed ID: 16585918
[TBL] [Abstract][Full Text] [Related]
12. [Modern aspects of diagnosis and treatment of chronic inflammatory demyelinating polyneuropathy in children].
Kozyreva AA; Bembeeva RT; Druzhinina ES; Zavadenko NN; Kolpakchi LM; Pilia SV
Zh Nevrol Psikhiatr Im S S Korsakova; 2024; 124(2):58-68. PubMed ID: 38465811
[TBL] [Abstract][Full Text] [Related]
13. Childhood chronic inflammatory demyelinating polyneuroradiculopathy--three cases and a review of the literature.
Riekhoff AG; Jadoul C; Mercelis R; Cras P; Ceulemans BP
Eur J Paediatr Neurol; 2012 Jul; 16(4):315-31. PubMed ID: 22225859
[TBL] [Abstract][Full Text] [Related]
14. Chronic inflammatory demyelinating polyradiculoneuropathy presenting as cauda equina syndrome in a diabetic.
Lai WW; Ubogu EE
J Neurol Sci; 2007 Sep; 260(1-2):267-70. PubMed ID: 17521674
[TBL] [Abstract][Full Text] [Related]
15. Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy. A double-blind, placebo-controlled, cross-over study.
Hahn AF; Bolton CF; Zochodne D; Feasby TE
Brain; 1996 Aug; 119 ( Pt 4)():1067-77. PubMed ID: 8813271
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of mycophenolate mofetil in patients with chronic immune demyelinating polyneuropathy.
Gorson KC; Amato AA; Ropper AH
Neurology; 2004 Aug; 63(4):715-7. PubMed ID: 15326250
[TBL] [Abstract][Full Text] [Related]
17. Timing and course of clinical response to intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy.
Latov N; Deng C; Dalakas MC; Bril V; Donofrio P; Hanna K; Hartung HP; Hughes RA; Merkies IS; van Doorn PA;
Arch Neurol; 2010 Jul; 67(7):802-7. PubMed ID: 20457948
[TBL] [Abstract][Full Text] [Related]
18. Management of chronic inflammatory demyelinating polyradiculoneuropathy.
Hughes RA
Drugs; 2003; 63(3):275-87. PubMed ID: 12534332
[TBL] [Abstract][Full Text] [Related]
19. Clinical trials in CIDP and chronic autoimmune demyelinating polyneuropathies.
Dalakas MC
J Peripher Nerv Syst; 2012 May; 17 Suppl 2():34-9. PubMed ID: 22548621
[TBL] [Abstract][Full Text] [Related]
20. Investigations and treatment of chronic inflammatory demyelinating polyradiculoneuropathy and other inflammatory demyelinating polyneuropathies.
Tracy JA; Dyck PJ
Curr Opin Neurol; 2010 Jun; 23(3):242-8. PubMed ID: 20389243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
